Table 2.
Advantages | Disadvantages |
---|---|
China’s large population enables large sample sizes | The Chinese approval process is complex and in lack of transparency |
Newly emerged problems require urgent attention and solution | The illogical guidance is draining limited resources |
Patients have a higher chance of developing NCD-related complications | The inconsistent management system leads to costly administration |
The quantity and quality of data have been advanced | Data quality cannot be guaranteed |
NCD: Noncommunicable disease.